Search / Trial NCT06232278

Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)

Launched by UNIVERSITY HOSPITAL, BREST · Jan 22, 2024

Trial Information

Current as of December 21, 2024

Active, not recruiting

Keywords

Left Atrial Appendage Occlusion · Watchman · Amplatzer Amulet · Atrial Fbrillation · Stroke · Echocardiography · Cardiac Computed Tomography Angiography

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Major
  • Non opposition
  • All patients with non-valvular atrial fibrillation and a definitive contraindication to anticoagulants who underwent left atrial appendage occlusion in the CHU of Brest between December 2014 and August 2023
  • Exclusion Criteria:
  • Minor
  • Patients under tutorship or curatorship
  • Formulated opposition

About University Hospital, Brest

The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.

Locations

Brest, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0